When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality

E-ISSN： 2212-3962|5|1|1-10

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.5, Iss.1, 2010-01, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension

Current Vascular Pharmacology, Vol. 10, Iss. 3, 2012-05 ,pp. : 289-299

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases

Current Vascular Pharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 59-65

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial Progenitor Cells - Isolation and Characterization

By Hristov M. Erl W. Weber P.C.

Trends in Cardiovascular Medicine, Vol. 13, Iss. 5, 2003-07 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis

By Akhavani M. A. Larsen H. Paleolog E.

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 2, 2007-01 ,pp. : 83-90

Informa Healthcare

Access to resources Recommend Favorite

“Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease

Current Vascular Pharmacology, Vol. 10, Iss. 1, 2012-01 ,pp. : 107-124

Bentham Science Publishers

Access to resources Recommend Favorite